Phase II Trial with High-Dose Elliptinium Acetate in Metastatic Renal Cell Carcinoma.

Autor: Piot, G., Droz, J.P., Theodore, C., Ghosn, M., Rouëssé, J., Amiel, J.L.
Zdroj: Oncology; 1988, Vol. 45 Issue 5, p371-372, 2p
Databáze: Complementary Index